For: | Joshi SK, Lucic N, Zuniga R. Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment. World J Neurol 2015; 5(3): 88-101 [DOI: 10.5316/wjn.v5.i3.88] |
---|---|
URL: | https://www.wjgnet.com/2218-6212/full/v5/i3/88.htm |
Number | Citing Articles |
1 |
Monika Witusik-Perkowska, Dariusz J. Jaskólski, Paweł P. Liberski, Janusz Szemraj. If Artificial In Vitro Microenvironment Can Influence Tumor Drug Resistance Network via Modulation of lncRNA Expression?—Comparative Analysis of Glioblastoma-Derived Cell Culture Models and Initial Tumors In Vivo. Cellular and Molecular Neurobiology 2022; 42(4): 1005 doi: 10.1007/s10571-020-00991-3
|
2 |
Cristina Almengló, Pilar Caamaño, Máximo Fraga, Jesús Devesa, José A. Costoya, Víctor M. Arce. From neural stem cells to glioblastoma: A natural history of GBM recapitulated in vitro. Journal of Cellular Physiology 2021; 236(11): 7390 doi: 10.1002/jcp.30409
|
3 |
Paul Kawak, Nour M. Al Sawaftah, William G. Pitt, Ghaleb A. Husseini. Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review. International Journal of Molecular Sciences 2023; 24(17): 13262 doi: 10.3390/ijms241713262
|